Champalimaud Research (CR) started with the Champalimaud Neuroscience Programme (CNP), created in 2007. It is a basic research team with the broad aim of understanding brain function through integrative biological approaches. The team is composed of 15 main research groups and 2 associated labs who study diverse topics in neuroscience using advanced, cutting edge techniques. Research groups apply advanced molecular, physiological and imaging tools to elucidate the function of neural circuits and systems in animal models that include Drosophila, mouse, rat and zebrafish.
In 2014, the Champalimaud Foundation established the Cancer Research Programme on an organismic approach to investigate the biology of cancer and metastasis. Understanding how cancer cells initiate, escape the host’s defence mechanisms, grow and metastasise, will depend on more than just understanding the biology of cancer cells. It will also depend on understanding how cancer cells interact with various host systems, including the vascular, immune, lymphatic and endocrine systems, and how these interactions change over time as the organism ages.
The Champalimaud Research leadership team has two directors, Zachary Mainen and Celso Matos and a Deputy Director, Marta Moita. The team works together to provide the environment and resources that will enable the achievement of CR's vision - to help scientists reach their full creative potential and promote collective achievements beyond those reachable by individual scientists or laboratory groups.
Since 2018, the Champalimaud Research leadership team has two members, Zachary Mainen (Co-Director) and Celso Matos (Co-Director). The team works together to provide the environment and resources that will enable the achievement of CR's vision - to help scientists reach their full creative potential and promote collective achievements beyond those reachable by individual scientists or laboratory groups. The Direction Team is supported by Marta Moita as Deputy Director.
The Champalimaud Foundation’s C-TRACER programme – Champalimaud Translational Centre for Eye Research - was launched in India in 2008 with the goal of supporting cutting-edge vision research. The C-TRACER is designed to reflect the Foundation’s belief in translational science which brings breakthroughs from the laboratory to the clinic, thus making a significant contribution to the prevention and eradication of vision related disease and illness around the World.